Cargando…

The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics

One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples. Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well suited for proteome studies. However, the protein r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mina, Lee, Sang-Hee, Min, Jiho, Kobayashi, Fumihisa, Um, Hyun-Ju, Kim, Yang-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196251/
https://www.ncbi.nlm.nih.gov/pubmed/22013380
http://dx.doi.org/10.1155/2011/213643
_version_ 1782214198787309568
author Kim, Mina
Lee, Sang-Hee
Min, Jiho
Kobayashi, Fumihisa
Um, Hyun-Ju
Kim, Yang-Hoon
author_facet Kim, Mina
Lee, Sang-Hee
Min, Jiho
Kobayashi, Fumihisa
Um, Hyun-Ju
Kim, Yang-Hoon
author_sort Kim, Mina
collection PubMed
description One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples. Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well suited for proteome studies. However, the protein recovery efficiency of such system is low when a protocol recommended by the manufacturer is used for metaproteome profiling of environmental sample. In search of an alternative method that can overcome existing limitations, this study replaced manufacturer's buffers with Triton X-100 during the PF2D evaluation of Escherichia coli K12. Three different Triton X-100 concentrations—0.1%, 0.15%, and 0.2%—were used for the first-dimension protein profiling. As the first-dimension result was at its best in the presence of 0.15% Triton X-100, second-dimension protein fractionation was performed using 0.15% Triton X-100 and the standard buffers. When 0.15% Triton X-100 was used, protein recovery increased as much as tenfold. The elution reliability of 0.15% Triton X-100 determined with ribonuclease A, insulin, α-lactalbumin, trypsin inhibitor, and cholecystokinin (CCK) affirmed Triton X-100 at 15% can outperform the standard buffers without having adverse effects on samples. This novel use of 0.15% Triton X-100 for PF2D can lead to greater research possibilities in the field of proteomics.
format Online
Article
Text
id pubmed-3196251
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31962512011-10-19 The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics Kim, Mina Lee, Sang-Hee Min, Jiho Kobayashi, Fumihisa Um, Hyun-Ju Kim, Yang-Hoon J Biomed Biotechnol Research Article One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples. Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well suited for proteome studies. However, the protein recovery efficiency of such system is low when a protocol recommended by the manufacturer is used for metaproteome profiling of environmental sample. In search of an alternative method that can overcome existing limitations, this study replaced manufacturer's buffers with Triton X-100 during the PF2D evaluation of Escherichia coli K12. Three different Triton X-100 concentrations—0.1%, 0.15%, and 0.2%—were used for the first-dimension protein profiling. As the first-dimension result was at its best in the presence of 0.15% Triton X-100, second-dimension protein fractionation was performed using 0.15% Triton X-100 and the standard buffers. When 0.15% Triton X-100 was used, protein recovery increased as much as tenfold. The elution reliability of 0.15% Triton X-100 determined with ribonuclease A, insulin, α-lactalbumin, trypsin inhibitor, and cholecystokinin (CCK) affirmed Triton X-100 at 15% can outperform the standard buffers without having adverse effects on samples. This novel use of 0.15% Triton X-100 for PF2D can lead to greater research possibilities in the field of proteomics. Hindawi Publishing Corporation 2011 2011-10-16 /pmc/articles/PMC3196251/ /pubmed/22013380 http://dx.doi.org/10.1155/2011/213643 Text en Copyright © 2011 Mina Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kim, Mina
Lee, Sang-Hee
Min, Jiho
Kobayashi, Fumihisa
Um, Hyun-Ju
Kim, Yang-Hoon
The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
title The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
title_full The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
title_fullStr The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
title_full_unstemmed The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
title_short The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics
title_sort utilization of triton x-100 for enhanced two-dimensional liquid-phase proteomics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196251/
https://www.ncbi.nlm.nih.gov/pubmed/22013380
http://dx.doi.org/10.1155/2011/213643
work_keys_str_mv AT kimmina theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT leesanghee theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT minjiho theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT kobayashifumihisa theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT umhyunju theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT kimyanghoon theutilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT kimmina utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT leesanghee utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT minjiho utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT kobayashifumihisa utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT umhyunju utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics
AT kimyanghoon utilizationoftritonx100forenhancedtwodimensionalliquidphaseproteomics